Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes.
Wu Q, Zhong L, Wei D, Zhang W, Hong J, Kang Y, Chen K, Huang Y, Zheng Q, Xu M, Zeng MS, Zeng YX, Xia N, Zhao Q, Krummenacher C, Chen Y, Zhang X.
Wu Q, et al. Among authors: xia n.
Emerg Microbes Infect. 2023 Dec;12(2):2245920. doi: 10.1080/22221751.2023.2245920.
Emerg Microbes Infect. 2023.
PMID: 37542379
Free PMC article.